Association between <i>CYP3A5</i> Polymorphism and Statin-Induced Adverse Events: A Systemic Review and Meta-Analysis
<b>Purpose:</b> Cytochrome P450 (CYP) is involved in the metabolism of statins; CYP3A5 is the main enzyme responsible for lipophilic statin metabolism. However, the evidence of the association between <i>CYP3A5*3</i> polymorphism and the risk of statin-induced adverse events...
Main Authors: | Jeong Yee, Hamin Kim, Yunhee Heo, Ha-Young Yoon, Gonjin Song, Hye-Sun Gwak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/677 |
Similar Items
-
Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo
by: Maria Alice Vieira Willrich
Published: (2011) -
Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo
by: Willrich, Maria Alice Vieira
Published: (2011) -
Pharmacogenetics of Statin-Induced Myotoxicity
by: Ping Siu Kee, et al.
Published: (2020-10-01) -
Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension
by: Liang H, et al.
Published: (2021-02-01) -
CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)